Ribonucleic Acid (RNA) Sequencing Global Market Report 2024 by The Business Research Company | F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc,

The ribonucleic acid (RNA) sequencing market size has grown exponentially in recent years. It will grow from $2.66 billion in 2023 to $7.29 billion in 2024 at a compound annual growth rate (CAGR) of 22.2%. The growth in the historic period can be attributed to rising number of drug development activities, growing prevalence of genetic disorders and target diseases, increasing use of miniaturized portable instruments, growing use of biomarker profiling, growing demand for personalized medicine, and the increasing number of cancer patients.

The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $7.29 billion in 2028 at a compound annual growth rate (CAGR) of 22.4%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Ribonucleic Acid (RNA) Sequencing Market Major Segments
The ribonucleic acid (RNA) sequencing market covered in this report is segmented -

1) By Product Type: Instruments, Reagents And Kits, Software
2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications
4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Key Driver - Rising Demand For Sustainable Automotive Technologies Propels Ethanol Car Market Growth

An increasing focus on precision medicine is expected to propel the growth of the ribonucleic acid (RNA) sequencing market going forward. Precision medicine or personalized medicine is an innovative approach to medical treatment and prevention that considers individual variability in genes, environment, and lifestyle for each person. Personalized medicine has the potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. RNA sequencing technologies are utilized to determine the sequence and quantify the expression levels of RNA molecules within a sample. It enables comprehensive analysis of transcriptomes and insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, increasing focus on precision medicine drives the ribonucleic acid (RNA) sequencing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15665&type=smp

Prominent Trend - Automation Advancements Driving Innovation In RNA Sequencing Market

Major companies operating in the ribonucleic acid (RNA) sequencing market focus on RNA next-generation sequencing assay to improve patient care through data-driven insights and precision medicine. RNA next-generation sequencing assay is a next-generation exome sequencing platform that leverages advanced genomic sequencing technologies to analyze a patient's entire exome. For instance, in June 2023, Tempus, a US-based precision medicine technology company, unveiled its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, designed for solid tumors, offers a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with a specific interest in RNA fusions or altered splicing and providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.

Ribonucleic Acid (RNA) Sequencing Market Players
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Genomics Inc, Natera Inc, Myriad Genetics Inc., BGI Genomics Co Ltd, Takara Bio Inc, Cepheid, NeoGenomics Laboratories Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Macrogen Inc, Standard BioTools Inc, Ambry Genetics Corporation, Biocartis SA, CD Genomics

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ribonucleic Acid (RNA) Sequencing Market Report Structure
3. Ribonucleic Acid (RNA) Sequencing Market Trends And Strategies
4. Ribonucleic Acid (RNA) Sequencing Market - Macro Economic Scenario
5. Ribonucleic Acid (RNA) Sequencing Market Size And Growth
…..
27. Ribonucleic Acid (RNA) Sequencing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.